Shattuck Labs (STTK) Operating Income (2019 - 2026)
Shattuck Labs' (STTK) quarterly Operating Income came in at -$15.5 million in Q1 2026, down 8.03% year-on-year from -$16.9 million in Q1 2025, and down 16.26% on a QoQ basis from -$13.4 million in Q4 2025.
Shattuck Labs (STTK) Operating Income (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Operating Income data on file, last reported at -$15.5 million in Q1 2026.
- On a quarterly basis, Operating Income fell 8.03% year-over-year to -$15.5 million in Q1 2026; TTM through Mar 2026 was -$52.7 million, a 29.7% increase from a year earlier, with the FY2025 full-year figure at -$51.5 million, up 36.07% from the prior year.
- Operating Income for Q1 2026 stood at -$15.5 million, down from -$13.4 million in the prior quarter.
- Over the last five years, Operating Income for STTK reached as high as -$10.7 million in Q3 2025 and fell as low as -$28.6 million in Q3 2023.
- Historically, Operating Income has averaged -$20.2 million across 5 years, with a median of -$20.0 million in 2024.
- Across the five-year window, Operating Income tumbled 384.19% in 2022 and surged 43.25% in 2025, its largest moves.
- Year by year, Operating Income stood at -$26.3 million in 2022, then gained by 27.88% to -$19.0 million in 2023, then slipped by 3.64% to -$19.6 million in 2024, then surged by 31.92% to -$13.4 million in 2025, then decreased by 16.26% to -$15.5 million in 2026.
- Per Business Quant data, the three most recent Operating Income figures were -$15.5 million in Q1 2026, -$13.4 million in Q4 2025, and -$10.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - | -15.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.55 Mn |
| Dec 31, 2025 | -13.37 Mn |
| Sep 30, 2025 | -10.72 Mn |
| Jun 30, 2025 | -13.03 Mn |
| Mar 31, 2025 | -14.39 Mn |
| Dec 31, 2024 | -19.64 Mn |
| Sep 30, 2024 | -17.92 Mn |
| Jun 30, 2024 | -22.96 Mn |
| Mar 31, 2024 | -20.04 Mn |
| Dec 31, 2023 | -18.95 Mn |
| Sep 30, 2023 | -28.60 Mn |
| Jun 30, 2023 | -22.75 Mn |
| Mar 31, 2023 | -21.66 Mn |
| Dec 31, 2022 | -26.28 Mn |
| Sep 30, 2022 | -25.23 Mn |
| Jun 30, 2022 | -27.66 Mn |
| Mar 31, 2022 | -24.17 Mn |
| Dec 31, 2021 | 9.25 Mn |
| Sep 30, 2021 | -17.58 Mn |
| Jun 30, 2021 | -24.51 Mn |